Abiomed Inc. (ABMD)

$ 381.02
   
  • Change Today:
    $0.00
  • 52 Week High: $381.02
  • 52 Week Low: $381.02
  • Currency: US Dollars
  • Shares Issued: 45.55m
  • Volume: 0
  • Market Cap: $17,354m
  • RiskGrade: 184

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Mar-22 31-Mar-21 31-Mar-20 31-Mar-19 31-Mar-18
Continuing Operations          
Revenue 1,031.75 847.52 840.88 769.43 593.75
Operating Profit/(Loss) 140.72 229.56 249.22 224.81 157.14
Profit Before Tax 190.56 288.52 256.83 263.36 160.44
Profit After Tax 136.51 225.52 203.01 259.02 112.17
           
Earnings per Share - Basic 300.00¢ 500.00¢ 449.00¢ 577.00¢ 254.00¢
Earnings per Share - Adjusted 300.00¢ 500.00¢ 449.00¢ 577.00¢ 254.00¢
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Mar-22 31-Mar-21 31-Mar-20 31-Mar-19 31-Mar-18
Assets          
Non-Current Assets          
Property, Plant & Equipment 202.49 197.13 164.93 145.01 117.17
Intangible Assets 116.30 120.72 31.97 32.60 35.81
Other Non-Current Assets 378.13 388.55 383.70 199.54 139.13
  696.92 706.39 580.60 377.15 292.10
Current Assets          
Inventories 93.98 81.06 90.09 80.94 50.20
Cash at Bank & in Hand 132.82 232.71 192.34 121.02 42.97
Other Current Assets 749.67 474.20 353.43 475.23 401.09
  976.47 787.97 635.86 677.20 494.27
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,673.39 1,494.36 1,216.46 1,054.35 786.38
Current Liabilities          
Borrowings n/a n/a n/a n/a n/a
Other Current Liabilities 138.46 128.97 131.88 106.00 84.68
           
Current Liabilities 138.46 128.97 131.88 106.00 84.68
           
Net Current Assets c838.02 c659.00 c503.98 c571.20 c409.59
           
Borrowings n/a n/a n/a n/a n/a
Other Non-Current Liabilities 31.61 35.72 19.11 11.46 12.17
Non-Current Liabilities 31.61 35.72 19.11 11.46 12.17
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 170.07 164.68 151.00 117.46 96.85
           
Net Assets 1,503.33 1,329.68 1,065.47 936.89 689.52
           
Shareholders Funds 1,503.33 1,329.68 1,065.47 936.89 689.52
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 1,503.33 1,329.68 1,065.47 936.89 689.52
Cash Flow 31-Mar-22 31-Mar-21 31-Mar-20 31-Mar-19 31-Mar-18
Net Cash Flow From Operating Activities n/a 274.58 314.92 252.20 192.55
Net Cash Flow from Investing Activities n/a (223.34) (125.46) (116.46) (180.76)
Net Cash Flow from Financing Activities n/a (10.86) (118.14) (57.70) (7.85)
Net Increase/Decrease In Cash n/a 40.37 71.32 78.05 3.93
Ratios - based on IFRS 31-Mar-22 31-Mar-21 31-Mar-20 31-Mar-19 31-Mar-18
Continuing Operations          
PE Ratio - Adjusted 110.4 63.7 32.3 49.5 114.6
PEG - Adjusted n/a 5.8 n/a 0.4 n/a
Earnings per Share Growth - Adjusted -40% 11% -22% 127% n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 2,265.35¢ 1,860.85¢ 1,846.27¢ 1,689.39¢ 1,303.65¢
Pre-Tax Profit per Share 418.40¢ 633.49¢ 563.89¢ 578.24¢ 352.26¢
Operating Margin 13.64% 27.09% 29.64% 29.22% 26.47%
Return on Capital Employed 13.74% 23.87% 24.85% 29.12% 24.54%
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share n/a 602.87¢ 691.45¢ 553.73¢ n/a
Cash Incr/Decr per Share n/a 88.64¢ 156.59¢ 171.36¢ 8.64¢
Net Asset Value per Share (exc. Intangibles) 3,045.39¢ 2,654.42¢ 2,269.18¢ 1,985.48¢ 1,435.32¢
Net Gearing n/a n/a n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page